Preview

Rational Pharmacotherapy in Cardiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 14, No 4 (2018) Hepatotoxicity of New Oral Anticoagulants Abstract  similar documents
A. R. Kasimova, A. V. Philippova (Guryanova), A. S. Kolbin
"... of various manifestations of liver damage in the use of the new oral anticoagulants (NOAC) for the registered ..."
 
Vol 13, No 5 (2017) DRUG INTERACTIONS OF NEW ORAL ANTICOAGULANTS: INSIDE AND OUTSIDE TABLE CELLS Abstract  similar documents
S. N. Bel'diev, I. V. Medvedeva, D. Yu. Platonov
"...   favorable profile of drug  interaction in comparison with other new oral anticoagulants (NOAC). The basis ..."
 
Vol 11, No 5 (2015) Cost-effectiveness of new oral anticoagulants in the treatment and secondary prevention of venous thromboembolism Abstract  similar documents
A. V. Rudakova
"... oral anticoagulants (NOACs). Material and methods. Cost-effectiveness analysis was performed using ..."
 
Vol 10, No 6 (2014) THE ASSESSMENT OF COMPLIANCE TO THE USE OF NEW ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION ACCORDING TO THE PROFILE REGISTER Abstract  similar documents
S. Y. Martsevich, A. R. Navasardyan, N. P. Kutishenko, A. V. Zakharova, V. P. Voronina, N. A. Dmitrieva, L. Yu. Lrozdova, A. V. Zagrebelnyy, O. V. Lerman, Yu. V. Lukina, G. V. Martynova, A. A. Nikulina, G. S. Ryazanova, A. Yu. Suvorov, S. N. Tolpygina
"... Aim. To study in the PROFILE register the rate of new oral anticoagulants (NOAC) taking ..."
 
Vol 10, No 6 (2014) THE PROBLEM OF THE USE OF NEW ORAL ANTICOAGULANTS IN CANCER PATIENTS RECEIVING CHEMOTHERAPY Abstract  similar documents
A. A. Rumyantsev, I. A. Pokataev, T. V. Kozlov, N. A. Rumyantsev
"... problems. New oral anticoagulants (NOAC) are promising drugs for use in oncology practice; however ..."
 
Vol 12, No 4 (2016) The use of oral anticoagulants in patients with atrial fibrillation: cohort study data Abstract  similar documents
O. V. Gaisenok, A. S. Leonov
"... Aim. To study the rate of prescription of oral anticoagulants (OAC) in patients with atrial ..."
 
Vol 12, No 3 (2016) THE ADVANCED TACTICS OF THE MANAGEMENT OF PATIENTS WITH VENOUS THROMBOEMBOLISM: THE ROLE OF RIVAROXABAN AT VARIOUS STAGES OF TREATMENT Abstract  PDF (Eng)  similar documents
S. R. Gilyarevskiy
"... , as well as the choice of anticoagulants, including new oral anticoagulants (NOAC). EINSTEIN-PE is the only ..."
 
Vol 12, No 1 (2016) Efficacy and safety of the new oral anticoagulants in the treatment of venous thromboembolic complications: meta-analysis Abstract  similar documents
V. I. Petrov, O. V. Shatalova, V. S. Gorbatenko, O. N. Smuseva, A. S. Maslakov
"... Aim. Analysis of the efficacy and safety of the new oral anticoagulants (NOACs) in the management ..."
 
Vol 14, No 4 (2018) Risk Controlling of Gastrointestinal Bleeding in Comorbid Patients with Cardiovascular Diseases Abstract  similar documents
O. Yu. Chizhova, L. N. Belousova, I. G. Bakulin
"... anticoagulants (NOACs), previously known as new oral anticoagulants are used in the treatment and prevention ..."
 
Vol 13, No 5 (2017) WARFARIN AND ITS IMPORTANCE IN THE ERA OF NEW ORAL ANTICOAGULANTS. ISSUES OF MONITORING THE EFFECTIVENESS AND SAFETY OF TREATMENT Abstract  similar documents
S. Yu. Martsevich, Y. V. Lukina
"... Oral anticoagulant (OAC) therapy is currently gaining special importance due to the significant ..."
 
Vol 12, No 4 (2016) Clinical significance of new oral anticoagulants in the prevention of thromboembolic complications in patients with atrial fibrillation: not all dreams come true Abstract  similar documents
Yu. A. Bunin, S. V. Miklishanskaya
"... . In connection with the known disadvantages of warfarin use, the elaboration of new oral anticoagulants (NOAC ..."
 
Vol 10, No 4 (2014) NEW ORAL ANTICOAGULANTS: FOCUS ON THE SAFETY Abstract  similar documents
D. A. Napalkov, A. A. Sokolova
"... Comparative analysis of oral anticoagulants (vitamin K antagonists and new drugs, including ..."
 
Vol 15, No 4 (2019) The Therapy with Oral Anticoagulants in Patients with Atrial Fibrillation in Outpatient and Hospital Settings (Data from RECVASA Registries) Abstract  similar documents
M. M. Loukianov, S. Yu. Martsevich, O. M. Drapkina, S. S. Yakushin, A. N. Vorobyev, K. G. Pereverzeva, A. V. Zagrebelnyy, V. Val. Yakusevich, V. Vl. Yakusevich, E. M. Pozdnyakova, T. A. Gomova, E. E. Fedotova, M. N Valiakhmetov, V. P. Mikhin, Yu. V. Maslennikova, E. Y. Andreenko, V. G. Klyashtorny, E. V. Kudryashov, E. Yu. Okshina, M. A. Panagopulu, S. A. Boytsov
"... -vitamin K antagonist oral anticoagulants (NOAC) – 518 (16%). Patients with permanent and persistant types ..."
 
Vol 12, No 5 (2016) Treatment Adherence as a New Choice Factor for Optimization of Oral Anticoagulation Therapy in Patients with Atrial Fibrillation and Hemostatic Gene Polymorphisms Abstract  PDF (Eng)  similar documents
Yu. P. Skirdenko, A. V. Shustov, V. V. Zherebilov, N. A. Nikolayev
"... .7%; Kolmogorov-Smirnov; p<0.05). Patients receiving new oral anticoagulants (NOAC) have better compliance ..."
 
Vol 13, No 3 (2017) PHARMACOGENETIC ASPECTS OF NEW ORAL ANTICOAGULANTS APPLICATION Abstract  similar documents
A. V. Kryukov, D. A. Sychev, O. V. Tereshchenko
"... parameters of new oral anticoagulants. The review presents data from studies investigating the effect of gene ..."
 
Vol 12, No 3 (2016) THE PHARMACOKINETICS OF APIXABAN IN PATIENTS WITH CARDIOEMBOLIC STROKE IN ACUTE PHASE Abstract  PDF (Eng)  similar documents
A. V. Kryukov, D. A. Sychev, D. A. Andreev, A. V. Ryabova, N. P. Denisenko, M. A. Loskutnikov, O. I. Vinogradov, M. A. Domashenko
"... to anticoagulation therapy in these patients. Keywords: new oral anticoagulants, apixaban, pharmacokinetics, atrial ..."
 
Vol 14, No 3 (2018) APPROACHES TO THE CHOICE OF ANTICOAGULANT THERAPY IN THE TREATMENT OF PATIENTS WITH COMBINATION OF ATRIAL FIBRILLATION WITH CORONARY HEART DISEASE OR PERIPHERAL ATHEROSCLEROSIS: POTENTIAL OF APIXABAN Abstract  similar documents
O. D. Ostroumova, A. I. Kochetkov, I. Yu. Orlova, E. A. Smolyarchuk, J. S. Pavlova
"... oral anticoagulants (NOAC) instead of vitamin K antagonists (eg, warfarin), low doses of NOAC, studied ..."
 
Vol 11, No 1 (2015) ON THE SELECTION OF DRUGS DOSAGE REGIMEN Abstract  similar documents
E. N. Bochanova
"... пероральных анти- коагулянтов (НОАК; ривароксабан, дабигатран) все шире применяются в клинической практике ..."
 
Vol 12, No 2 (2016) THE EFFICACY AND SAFETY OF NEW ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION IN CLINICAL PRACTICE Abstract  similar documents
S. V. Moiseev
"... New oral anticoagulants that inhibit factor Xa (rivaroxaban, apixaban, edoksaban) or thrombin ..."
 
Vol 14, No 6 (2018) Specific Antidotes for Direct Oral Anticoagulants in Life-Threatening Bleeding Abstract  PDF (Eng)  similar documents
A. B. Sumarokov, L. I. Buryachkovskaya, N. V. Lomakin
"... taking new oral anticoagulants. Information concerning use of antidotes for DOACs in bleedings as well ..."
 
Vol 12, No 4 (2016) Application of rivaroxaban in clinical practice: results of a prospective observational study XANTUS in patients with atrial fibrillation Abstract  similar documents
S. G. Kanorskii
"... антикоагулянтов [2-4]. У пациентов с неклапанной ФП новые пероральные антикоагулянты (НОАК: апик- сабан ..."
 
Vol 9, No 4 (2013) COMPARATIVE EFFICACY AND SAFETY OF NEW ORAL ANTICOAGULANTS Abstract  similar documents
V. A. Sulimov, D. A. Napalkov, A. A. Sokolova
"... Indirect comparisons of new oral anticoagulants are performed with focus on their safety. Apixaban ..."
 
Vol 13, No 2 (2017) ORAL ANTICOAGULANTS IN AMBULATORY AND IN-HOSPITAL TREATMENT OF PATIENTS WITH ATRIAL FIBRILLATION ASSOCIATED WITH HYPERTENSION, ISCHEMIC HEART DISEASE AND CHRONIC HEART FAILURE: DATA FROM HOSPITAL REGISTRY RECVASA-CLINIC Abstract  PDF (Eng)  similar documents
E. V. Stepina, M. M. Loukianov, M. A. Bichurina, E. N. Belova, E. V. Kudryashov, Ju. V. Uzkov, S. A. Boytsov
"... Aim. To estimate the rate of oral anticoagulants (OAC) prescription, continuity of anticoagulant ..."
 
Vol 12, No 2 (2016) ATRIAL FIBRILLATION AND ISCHEMIC HEART DISEASE: HOW TO COMBINE ANTIPLATELET AND ANTICOAGULANT THERAPY, DEPENDING ON THE CLINICAL SITUATION? Abstract  similar documents
D. A. Napalkov, A. A. Sokolova, A. V. Rodionov
"... , direct oral anticoagulant, apixaban. Ration Pharmacother Cardiol 2016;12(21):191-195 DOI: http://dx ..."
 
Vol 11, No 6 (2015) Clinical and economic analysis of the use of apixaban for the treatment of venous thromboembolic events Abstract  similar documents
O. V. Shatalova
"... степенью антикоагуляции и длительностью приема антикоагулянтов на амбула- торном этапе лечения ..."
 
Vol 11, No 2 (2015) PRACTICAL ASPECTS OF APIXABAN USE IN CLINICAL PRACTICE: VIEW POINT OF CLINICAL PHARMACOLOGIST Abstract  similar documents
D. A. Sychev, I. I. Sinitsina, G. Yu. Zakharova, M. I. Savel'eva, A. V. Ryabova, A. V. Kryukov, A. Yu. Yurovskii
"... Apixaban is a "new" oral anticoagulant, direct Xa factor inhibitor with a good evidence base ..."
 
Vol 15, No 1 (2019) Assessment of Antithrombotic Therapy in Patients with Atrial Fibrillation for 2015-2017 According to the Registry of the Clinic of the Scientific Research Institute of Medical Problems of the North of Krasnoyarsk City Abstract  similar documents
A. A. Tuchkov, N. G. Gogolashvili, R. A. Yaskevich
"... of oral anticoagulants (ОAC) in patients with atrial fibrillation (AF) in 2015-2017. Material and methods ..."
 
Vol 15, No 4 (2019) Optimization of Pharmacotherapy with Direct Oral Anticoagulants: the Need to Choose the Right Dosage Regimen Abstract  similar documents
A. I. Kochetkov, O. D. Ostroumova
"... of direct oral anticoagulants (DOACs) compared with vitamin K antagonists due to the extensive body ..."
 
Vol 9, No 5 (2013) APPLICATIONS OF PHARMACOGENETIC TESTING FOR PERSONALIZATION OF THERAPY WITH ORAL ANTICOAGULANTS IN RUSSIA Abstract  similar documents
D. A. Sychev, R. E. Kazakov, V. A. Otdelenov, A. B. Prokofiev
"... response to oral anticoagulants is considered. Possible tactics of warfarin dosing and new oral ..."
 
Vol 12, No 5 (2016) Features of Modern Anticoagulant Therapy in Patients with Nonvalvular Atrial Fibrillation and Chronic Kidney Disease Abstract  similar documents
I. S. Daabul, A. A. Sokolova, D. A. Napalkov
"... of new medicines, more convenient in use. Direct oral anticoagulants were easier to use, and by results ..."
 
Vol 11, No 2 (2015) CHRONIC KIDNEY DISEASE AND CARDIOVASCULAR DISEASES: FOCUS ON ATRIAL FIBRILLATION Abstract  similar documents
V. N. Shishkova
"... антикоагулянты Новые пероральные антикоагулянты (НОАК) имеют механизмы действия и свойства, отличающиеся от та ..."
 
Vol 14, No 2 (2018) NEW DIRECT ORAL ANTICOAGULANTS FOR TREATMENT OF PATIENTS WITH ATRIAL FIBRILLATION IN REAL-WORLD SETTING Abstract  similar documents
Zh. D. Kobalava, S. V. Villevalde, A. A. Shavarov
"... ) showed that new direct oral anticoagulants (DOACs) were just as effective at preventing stroke ..."
 
Vol 13, No 1 (2017) DATA OF CLINICAL PRACTICE AS A TOOL FOR CHOICE OF DIRECT ORAL ANTICOAGULANT Abstract  similar documents
D. А. Napalkov, A. A. Sokolova, V. V. Fomin
"... . The analysis of various RCP data bases published over the past 2 years shows that, among all new oral ..."
 
Vol 14, No 1 (2018) NEW APPROACHES TO INDIVIDUALIZED CHOICE OF ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION Abstract  similar documents
Ju. P. Skirdenko, N. A. Nikolayev
"... as predictors of choice of optimal anticoagulant therapy in patients with atrial fibrillation (AF). Material ..."
 
Vol 11, No 2 (2015) ANTICOAGULANT THERAPY IN EVERYDAY CLINICAL PRACTICE: DATA OF THE RETROSPECTIVE CROSS-SECTIONAL STUDY Abstract  PDF (Eng)  similar documents
V. A. Sulimov, D. A. Napalkov, A. A. Sokolova, A. V. Jilenko, O. S. Anikina
"... % of the patients received novel oral anticoagulants (dabigatran – 14%, rivaroxaban – 2%). Bleeding was fixed in 4 ..."
 
Vol 9, No 2 (2013) ERA OF NEW ANTICOAGULANTS IN THE TREATMENT OF NON-VALVULAR ATRIAL FIBRILLATION: PROSPECTS AND CHALLENGES Abstract  similar documents
Z. M. Safiullina, S. V. Shalaev
"... Studies data on new anticoagulants, direct oral thrombin inhibitor (dabigatran) and direct ..."
 
Vol 14, No 6 (2018) Anticoagulant Therapy in “Fragile” Elderly Patients: Current State of the Problem Abstract  PDF (Eng)  similar documents
N. M. Vorobyeva, O. N. Tkacheva
"... The review focuses on the use of oral anticoagulants in fragile elderly patients. The issues ..."
 
Vol 9, No 5 (2013) PRACTICAL APPLICATION OF DABIGATRAN ETEXILATE FOR STROKE PREVENTION IN PATIENTS WITH ATRIAL FIBRILLATION Abstract  similar documents
E. D. Kosmacheva, S. G. Kanorskiy, A. A. Kastanayan, N. V. Haylo, D. B. Goltyapin, E. A. Lipnitskaya, M. E. Statsenko
"... Disadvantages of vitamin K antagonist warfarin and the benefits of new anticoagulants, including ..."
 
Vol 7, No 5 (2011) ANTITHROMBOTIC THERAPY IN ATRIAL FIBRILLATION: RECENT APPROACHES AND NEAR PERSPECTIVES Abstract  similar documents
Ya. P. Dovgalevskiy, L. E. Kuvshinova, I. V. Graifer, N. V. Furman, P. Ya. Dovgalevskiy
"... prevention in AF patients are presented. Special attention paid to new agents for oral anticoagulation ..."
 
Vol 15, No 4 (2019) Safety of Using Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Chronic Kidney Disease Abstract  similar documents
V. I. Petrov, O. V. Shatalova, A. S. Gerasimenko, V. S. Gorbatenko
"... oral anticoagulants for the prevention of thromboembolic complications in patients with atrial ..."
 
Vol 15, No 2 (2019) Studies of Anticoagulant Therapy in Frail Elderly Patients: Problems of Terminology and Methodology Abstract  similar documents
S. N. Bel'diev, I. V. Medvedeva, D. Yu. Platonov, G. Yu. Trufanova
"... oral anticoagulants (NOAC): 1) none of the randomized controlled trials (RCTs) with NOAC (except ..."
 
Vol 14, No 2 (2018) WHAT DO PATIENTS WITH ATRIAL FIBRILLATION KNOW ABOUT STROKE AND SYSTEMIC EMBOLISM PREVENTION? DATA OF THE PRIMA-TERRA REGISTRY Abstract  similar documents
R. М. Linchak, O. G. Kompaniyets, A. M. Nedbaykin
"... warfarin, 15% new oral anticoagulants (NOAC). The majority of patients received antiplatelet agents ..."
 
Vol 11, No 3 (2015) ANALYSIS OF THE INFLUENCE OF THROMBOEMBOLIC COMPLICATIONS PREVENTION WITH ORAL ANTICOAGULANTS ON BUDGET IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION Abstract  similar documents
A. V. Rudakova
"... administration of vitamin K antagonists (warfarin) or the new oral anticoagulants (apixaban, dabigatran ..."
 
Vol 13, No 6 (2017) PREDICTORS OF THE RISK OF HEMORRHAGIC EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION RECEIVING LONGTERM THERAPY WITH DIRECT ORAL ANTICOAGULANTS Abstract  similar documents
A. А. Sokolova, A. V. Zhilenko, I. L. Tsarev,, D. A. Napalkov, V. V. Fomin
"... the development of bleeding during anticoagulant therapy with direct oral anticoagulants (DOAC). Material ..."
 
Vol 14, No 3 (2018) THROMBOSIS OF LEFT ATRIAL APPENDAGE DURING THERAPY WITH DIRECT ORAL ANTICOAGULANT. CLINICAL CASE Abstract  similar documents
I. S. Daaboul, S. Yu. Koroleva, A. A. Kudrjavtseva, A. A. Sokolova, D. A. Napalkov, V. V. Fomin
"... , it was decided to replace apixaban with another direct oral anticoagulant – dabigatran 150 mg bid for a period ..."
 
Vol 10, No 4 (2014) MODERN APPROACHES TO ANTICOAGULANT THERAPY DURING CATHETER ABLATION TREATMENT OF NON-VALVULAR ATRIAL FIBRILLATION Abstract  similar documents
E. A. Belikov, K. V. Davtyan, O. N. Tkacheva
"... anticoagulants. ..."
 
Vol 13, No 5 (2017) ADHERENCE TO THE USE OF NEW ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION – THE WAY TO SOLVE THE PROBLEM OF EFFICACY AND SAFETY OF TREATMENT Abstract  similar documents
S. G. Kanorskii
"... and patients with concomitant diseases. Taking an oral anticoagulant, not vitamin K antagonists, in particular ..."
 
Vol 11, No 1 (2015) PHARMACOECONOMIC ASPECTS OF APIXABAN FOR PREVENTION OF THROMBOEMBOLIC EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION Abstract  similar documents
A. V. Rudakova
"... (warfarin), antiplatelet therapy (acetylsalicylic acid) and novel oral anticoagulants such as apixaban ..."
 
Vol 10, No 3 (2014) COST-EFFECTIVENESS OF APIXABAN AS COMPARED WITH WARFARIN AND ACETYLSALICYLIC ACID IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION IN THE RUSSIAN FEDERATION Abstract  similar documents
A. V. Rudakova, V. A. Parfenov
"... fibrillation (NVAF) the following types of antithrombotic therapy are used: anticoagulant therapy with vitamin ..."
 
Vol 12, No 5 (2016) Dabigatran Etexilate in the course of Electrical Cardioversion in Patients with Non-Valvular Atrial Fibrillation Abstract  similar documents
N. A. Novikova, A. N. Volovchenko
"... lately new oral anticoagulants (NOAC) are becoming more common for the prevention of thromboembolic ..."
 
Vol 5, No 1 (2009) CURRENT PRINCIPLES AND TRENDS OF ATRIAL FIBRILLATION PHARMACOTHERAPY Abstract  similar documents
Yu. A. Bunin
"... stratification) of different antiarrhythmic drugs and anticoagulants are described. Perspectives in improvement ..."
 
Vol 13, No 1 (2017) ANTIPLATELET THERAPY OF ATRIAL FIBRILLATION: FOCUS ON THE ELDERLY Abstract  similar documents
E. А. Ushkalova, S. K. Zyryanov, E. V. Dumchenko
"... candidates for anticoagulant therapy for reasons other  than  bleeding risk or those  who refuse to take oral ..."
 
Vol 2, No 3 (2006) EFFICACY OF THERAPY WITH INDIRECT ANTICOAGULANTS: ROLE OF THE FOODSTUFF VITAMIN K CONTENTS Abstract  similar documents
A. P. Momot, O. V. Bespalova, E. N. Vorobyova
"... The anticoagulants of indirect action during many years serve drugs of basic prophylaxis ..."
 
Vol 5, No 3 (2009) ANTICOAGULANTS IN ACUTE CORONARY SYNDROME Abstract  similar documents
I. A. Latfullin, A. A. Podolskaya
"... Рациональная Фармакотерапия в Кардиологии 2009;№3 71 ПРИМЕНЕНИЕ АНТИКОАГУЛЯНТОВ ПРИ ОСТРОМ ..."
 
Vol 8, No 4 (2012) THE RISK OF BLEEDINGS IN PATIENTS WITH ATRIAL FIBRILLATION DURING ANTICOAGULANT THERAPY Abstract  similar documents
M. Yu. Gilyarov
"... ФИБРИЛЛЯЦИЕЙ ПРЕДСЕРДИЙ НА ФОНЕ ПРИЕМА АНТИКОАГУЛЯНТОВ М. Ю. Гиляров* Первый Московский медицинский ..."
 
Vol 14, No 4 (2018) Physician’s Adherence to Clinical Guidelines for in-Hospital Anticoagulant Prescribing Abstract  similar documents
A. A. Chernov, E. V. Kleymenova, D. A. Sychev, L. P. Yashina, M. D. Nigmatkulova, V. A. Otdelenov, S. A. Payushchik
"... patients, including warfarin (39.5%), direct oral anticoagulants (DOAC) (46.5%) and low-molecular weight ..."
 
Vol 10, No 3 (2014) PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN ATRIAL FIBRILLATION - RAT POISON OR NEW ORAL ANTICOAGULANTS: DO WE HAVE A CHOICE, AND SHOULD WE BE AFRAID TO MAKE IT? FIRST CLINICAL EXPERIENCE WITH RIVAROXABAN IN NIZHNY NOVGOROD Abstract  similar documents
L. Y. Koroleva, I. V. Kolesnichenko, V. P. Nosov, I. I. Gritsenko, E. S. Timoschenko
"... , unfortunately, did not lead to wider and more efficient use of anticoagulation therapy. New oral anticoagulants ..."
 
Vol 14, No 5 (2018) Anticoagulant Therapy in Difficult Patients with Atrial Fibrillation: When the Risks of Embolism and Bleeding Are Comparable Abstract  similar documents
D. A. Napalkov, A. A. Sokolova, M. A. Gabitova, L. N. Uddin
"... This article affects  the problems of using NOAC in the most defenseless groups  of patients ..."
 
Vol 10, No 4 (2014) FEATURES OF THE CARDIOVERSION IN ATRIAL FLUTTER AND FIBRILLATION IN ERA OF NEW ANTICOAGULANTS: PRACTICAL CARDIOLOGIST VIEW Abstract  similar documents
S. A. Zenin, A. V. Fedoseenko, O. V. Kononenko, O. V. Pyataeva
"... base and analysis of complications of different anticoagulants use for safety of sinus rhythm ..."
 
Vol 11, No 3 (2015) PHARMACOECONOMIC ASPECTS OF THE PREVENTION OF VENOUS THROMBOEMBOLIC EVENTS AFTER LARGE JOINTS REPLACEMENT Abstract  similar documents
A. V. Rudakova
"... or oral anticoagulants that differ significantly in their efficacy, safety and cost of the therapy. Aim ..."
 
Vol 14, No 1 (2018) UTILIZING ENOXAPARIN IN THE MANAGEMENT OF ACUTE CORONARY SYNDROME Abstract  similar documents
O. V. Krikunova, R. I. Stryuk
"... Anticoagulant therapy is widely used in all forms of acute coronary syndrome (ACS) to inhibit ..."
 
Vol 15, No 4 (2019) Elderly Patients with Atrial Fibrillation: Focus on Comorbidity and Safety of Anticoagulant Therapy Abstract  similar documents
D. A. Napalkov, A. A. Sokolova
"... and cohort trials). The use of unreasonably low doses of oral anticoagulants in elderly patients is debated ..."
 
Vol 9, No 6 (2013) THE ROLE OF P-GLYCOPROTEIN IN RATIONAL PHARMACOTHERAPY IN CARDIOLOGY Abstract  similar documents
A. V. Shulkin, E. N. Yakusheva, N. M. Popova
"... agents and anticoagulants. Determination of C3435T polymorphism of multidrug resistance gene (MDR1 ..."
 
Vol 3, No 2 (2007) VARFARIN DOSE REGIME APPROACHS BASED ON PHARMACOGENETICS TEST RESULTS: REAL POSSIBILITY TO OPTIMIZE THE PHARMACOTHERAPY Abstract  similar documents
D. A. Sychev, I. M. Antonov, S. V. Zagrebin, N. A. Gasanov, V. G. Kukes
"... Indirect anticoagulants effectively prevent thromboembolic complications in patients with high ..."
 
Vol 4, No 2 (2008) ANTICOAGULANTS IN THERAPY OF PATIENTS WITH ACUTE CORONARY SYNDROME WITHOUT ST SEGMENT ELEVATION: WHICH DRUG TO BE CHOSEN? Abstract  similar documents
A. L. Komarov, E. P. Panchenko
"... Problem of anticoagulant choice in patients with acute coronary syndrome (ACS) is discussed ..."
 
Vol 14, No 4 (2018) Possibilities of Using Rivaroxaban in Elderly Patients with Atrial Fibrillation: Data from Randomized Studies and Real Clinical Practice Abstract  similar documents
N. M. Vorobyeva, O. N. kacheva
"... of anticoagulants in real clinical practice and questions of adherence of patients to anticoagulant therapy ..."
 
Vol 14, No 6 (2018) Antithrombotic Therapy in Patients with Atrial Fibrillation after Myocardial Infarction: Clinical Guidelines and Actual Practice Abstract  PDF (Eng)  similar documents
K. G. Pereverzeva, S. S. Yakushin, A. E. Pripadcheva, N. P. Agaltsova
"... Aim. To study the frequency of oral anticoagulants (ОАС) prescription for patients with atrial ..."
 
Vol 9, No 2 (2013) ANTITHROMBOTIC THERAPY SAFETY MONITORING BASED ON SPONTANEOUS REPORTS Abstract  similar documents
O. V. Shatalova, O. N. Smuseva, A. S. Maslakov
"... accounted for by indirect- acting anticoagulating agents — 66.7% (12/18), direct-acting anticoagulants — 22 ..."
 
Vol 7, No 3 (2011) STROKE PREVENTION IN INTERNIST PRACTICE Abstract  similar documents
D. A. Napalkov, A. V. Zhilenko
"... guidelines. Modern pharmacotherapy includes antiaggregants or anticoagulants, statins, and antihypertensive ..."
 
Vol 15, No 3 (2019) Features of Thromboembolic and Hemorrhagic Complications in Planned Surgical Interventions in Patients with Atrial Fibrillation Abstract  similar documents
L. N. Uddin, A. V. Egorov, A. A. Sokolova, N. S. Morozova, D. A. Napalkov, V. V. Fomin
"... of canceling oral anticoagulants in 107 (50.0%) patients. Conclusion. A significantly higher frequency ..."
 
Vol 5, No 3 (2009) SAFETY OF LONGTERM THERAPY WITH WARFARIN: POSSIBILITY OF TREATMENT RENEWING AFTER HEMORRHAGIC COMPLICATIONS Abstract  similar documents
E. S. Kropacheva
"... The safety of anticoagulant therapy is discussed. Warfarin position in prevention of thrombotic ..."
 
Vol 9, No 3 (2013) ANTICOAGULANT THERAPY IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION: DRUG CHOICE AND DOSAGE ADJUSTMENT Abstract  similar documents
E. L. Dolgova, I. M. Sokolov, Yu. G. Shvarts
"... are presented. Peculiarities of anticoagulant therapy to prevent thromboembolic complications, the difficulties ..."
 
Vol 13, No 6 (2017) ATRIAL FIBRILLATION AND CHRONIC HEART FAILURE: PRACTICAL ASPECTS AND DISCUSSION ISSUES OF RATIONAL PHARMACOTHERAPY Abstract  similar documents
Yu. А. Bunin, S. V. Miklishanskaya
"... antiarrhythmics and not antiarrhythmic drugs, anticoagulants and non-drug treatments in these patients. Based ..."
 
Vol 14, No 4 (2018) Elderly Patient Management Problems: Antithrombotic Therapy Selection Features. Clinical Case Abstract  similar documents
D. U. Akasheva, E. S. Bulgakova, I. S. Yavelov, A. Yu. Gorshkov, O. M. Drapkina
 
Vol 6, No 5 (2010) THE INVASIVE DENTAL PROCEDURES IN PATIENTS TREATING WITH WARFARIN: POSSIBILITIES AND PROSPECTS FOR SAFETY Abstract  similar documents
T. V. Kozlova, I. M. Makeyeva, V. Y. Doroshina, S. I. Bokareva
"... Details of the management of patients receiving oral anticoagulants (vitamin K antagonists ..."
 
Vol 8, No 6 (2012) HOW TO USE DABIGATRAN IN PATIENTS WITH ATRIAL FIBRILLATION Abstract  similar documents
S. V. Moiseev
"... Dabigatran is the new oral anticoagulant that directly inhibits thrombin (factor IIa). In RE-LY ..."
 
Vol 13, No 1 (2017) EVALUATION OF TREATMENT OF PATIENTS WITH ACUTE MYOCARDIAL INFARCTION BEFORE REFERENCE EVENT AND BEFORE DISCHARGE FROM THE HOSPITAL: REGISTER DATA (KHABAROVSK CITY). PART 2 Abstract  similar documents
L. N. Malay, S. Yu. Martsevich, L. V. Solokhina, Y. M. Bukhonkina, K. E. Poshatayev, N. B. Garayeva, A. Ya. Letskin
"... only 7 ones (17%) were treated with oral anticoagulants.        141 patients (79.6%) with STEMI ..."
 
Vol 8, No 4 (2012) WARFARIN IN PATIENTS WITH CARDIOEMBOLIC STROKE Abstract  similar documents
E. N. Dankovtseva, S. L. Arkhipov, D. A. Zateyshchikov
"... and the use of anticoagulants after cardioembolic stroke is discussed. ..."
 
Vol 7, No 4 (2011) LEFT VENTRICULAR CLOT LYSIS DUE TO COMBINED ANTICOAGULANT THERAPY WITH WARFARIN AND FRAXIPARINE IN PATIENT WITH DILATED CARDIOMYOPATHY AND CHRONIC HEART FAILURE. THE CLINICAL CASE Abstract  similar documents
O. V. Uskova, K. O. Sobolev, G. E. Gendlin, A. V. Melekhov
"... anticoagulant therapy with warfarin and fraxiparine in patient with dilated cardiomyopathy, congestive heart ..."
 
Vol 15, No 2 (2019) How to solve the problem of drug choice within the same class from the standpoint of evidence-based medicine? Abstract  similar documents
S. Yu. Martsevich
"... of different classes of drugs (beta-blockers, angiotensin-converting enzyme inhibitors, and new oral ..."
 
Vol 15, No 1 (2019) Comparative Analysis of Antithrombotic Therapy in In-Patients with Atrial Fibrillation Abstract  similar documents
V. I. Petrov, O. V. Shatalova, A. S. Gerasimenko, V. S. Gorbatenko
"... antagonists (warfarin) or with direct oral anticoagulants. A high risk of thromboembolic complications (CHA2DS ..."
 
Vol 14, No 2 (2018) DOCTOR’S ADHERENCE TO RECOMMENDATIONS GOVERNING THE ANTIPLATELET AGENTS USE IN THE CARDIOVASCULAR DISEASES PREVENTION AND TREATMENT Abstract  similar documents
N. В. Perepech, A. V. Tregubov
"... , if the patient with atrial fibrillation and a high risk of thromboembolism refused to take oral anticoagulants ..."
 
Vol 8, No 5 (2012) RISK OF THROMBOEMBOLIC COMPLICATIONS AND ANTITHROMBOTIC THERAPY IN IN-PATIENTS WITH PERMANENT AND RECURRENT ATRIAL FIBRILLATION IN REAL CLINICAL PRACTICE Abstract  similar documents
I. V. Grajfer, L. E. Kuvshinova, P. V. Dolotovskaya, O. V. Reshet'ko, N. V. Furman
"... ,05).  Conclusion. In real clinical practice oral anticoagulants are prescribed insufficiently in patients at high ..."
 
Vol 12, No 5 (2016) The Anticoagulation in Patients with Atrial Fibrillation: Rivaroxaban and Warfarin Abstract  similar documents
I. Yu. Koroleva, I. V. Kolesnichenko, V. P. Nosov, M. V. Zlobin, D. I. Abelevich
"... , unaddressed questions, and pragmatic issues of the newer oral anticoagulants for stroke prophylaxis in non ..."
 
Vol 12, No 1 (2016) Interaction of rivaroxaban with amiodarone, verapamil and diltiazem in patients with atrial fibrillation: terra incognita Abstract  similar documents
S. N. Bel'diev
"... , в таб- лице «Лекарственные взаимодействия и выбор дозы но- вых пероральных антикоагулянтов (НОАК ..."
 
Vol 8, No 6 (2012) RATIONAL PHARMACOTHERAPY IN TAKOTSUBO CARDIOMYOPATHY Abstract  similar documents
S. Marchev, T. Vekov
"... months is recommended. The duration of anticoagulant therapy may be modified depending on the extent ..."
 
Vol 14, No 1 (2018) COMPARATIVE ANALYSIS OF HOSPITAL PHARMACOTHERAPY OF CHRONIC HEART FAILURE WITH REDUCED LEFT VENTRICULAR EJECTION FRACTIONS IN 2009-2010 AND 2014-2015 Abstract  similar documents
O. V. Reshetko, A. V. Sokolov, E. V. Rykalina, N. V. Furman
"... receptors (AMCR), diuretics, oral anticoagulants, clopidogrel increased (p<0.05). In the structure ..."
 
Vol 12, No 1 (2016) The Moriscos-Green scale: the pros and cons of universal test, correction of mistakes Abstract  PDF (Eng)  similar documents
Yu. V. Lukina, S. Yu. Martsevich, N. P. Kutishenko
"... , Zakharova AV. Assessment of adherence to the ad- mission of new oral anticoagulants (PLA) in patients ..."
 
Vol 12, No 6 (2016) THE USE OF ENOXAPARIN IN ACUTE CORONARY SYNDROME Abstract  similar documents
E. A. Smirnova, S. S. Yakushin
"... The article discusses the choice of anticoagulant in different patterns of acute coronary syndrome ..."
 
Vol 13, No 1 (2017) CLINICAL AND ECONOMICAL COMPARISON OF RIVAROXABAN AND APIXABAN USE IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION Abstract  similar documents
S. V. Nedogoda, I. N. Barykina, A. S. Salasiuk, V. O. Smirnova
"... . Assessment of the likelihood of cerebrovascular complications during anticoagulant therapy was performed ..."
 
Vol 7, No 1 (2011) ANTIARRHYTHMIC EFFICACY OF PROPAFENONE IN PATIENTS WITH PERSISTENT ATRIAL FIBRILLATION Abstract  similar documents
R. D. Kurbanov, N. U. Zakirov, Sh. K. Azizov
"... to standard treatment of the underlying disease and oral anticoagulants. The first dose of propafenone was 300 ..."
 
Vol 13, No 1 (2017) THE STUDY "REGISTER OF PATIENTS AFTER ACUTE STROKE (REGION)". PART 2. OUTPATIENT PROSPECTIVE REGISTER OF PATIENTS AFTER ACUTE STROKE (ACCORDING TO THE RESULTS OF THE PILOT PHASE OF THE STUDY) Abstract  PDF (Eng)  similar documents
S. А. Boytsov, M. M. Loukianov, S. S. Yakushin, S. Yu. Martsevich, L. V. Stakhovskaya, A. N. Vorobyev, A. V. Zagrebelnyy, N. P. Kutishenko, A. N. Kozminsky, K. A. Moseichuk, K. G. Pereverzeva, E. A. Pravkina, E. N. Belova, E. V. Kudryashov, A. D. Deev
"... %, and anticoagulants in atrial fibrillation – 17.6% vs 2.3%, respectively). Mortality rates in the ACVA-AR and ACVA-FV ..."
 
Vol 9, No 4 (2013) COMPARISON OF DIRECT COSTS OF DABIGATRAN AND WARFARIN THERAPY IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION DURING PREPARATION FOR ELECTIVE CARDIOVERSION IN THE REAL CLINICAL PRACTICE Abstract  similar documents
L. E. Kuvshinova, N. V. Furman, P. V. Dolotovskaya, Ya. P. Dovgalevsky
"... антикоагулянты (НОАК) хотя и обла- дают клиническим преимуществом перед варфарином, однако их применение ..."
 
Vol 14, No 5 (2018) Drug Therapy Structure and Clinical Characteristics of Patients with Atrial Fibrillation According to Data of REKUR-AF Study Abstract  similar documents
I. L. Polshakova, S. V. Povetkin
"... enzyme  inhibitors, β-blockers, statins and  diuretics. Anticoagulants were  only used  in 18 ..."
 
Vol 10, No 2 (2014) RIVAROXABAN IN PATIENTS STABILIZED AFTER A ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION. RESULTS FROM THE ATLAS ACS-2–TIMI-51 TRIAL Abstract  similar documents
J. L. Mega, E. Braunwald, S. A. Murphy, A. N. Plotnikov, P. Burton, R. G. Kiss, A. Parkhomenko, M. Tendera, P. Widimsky, C. M. Gibson
"... увеличивал существенно частоту смертельных кровотечений. Ключевые слова: антикоагулянт, инфаркт миокарда с ..."
 
Vol 5, No 4 (2009) GASTROENTEROPATHIES ASSOCIATED WITH ACETYLSALICYLIC ACID: HOW TO IMPROVE SAFETY OF THERAPY Abstract  similar documents
A. L. Komarov
"... . It is necessary if possible to avoid ASK usage in combination with other antiaggregants, anticoagulants, non ..."
 
Vol 12, No 6 (2016) NEW DATA OF EXTENSIVE RESEARCH PROGRAM AND THE RESULTS OF STUDIES IN REAL CLINICAL PRACTICE FROM DIFFERENT COUNTRIES REAFFIRMED THE HIGH EFFICACY AND A FAVORABLE SAFETY PROFILE OF RIVAROXABAN (XARELTO®) FROM THE BAYER COMPANY PRESS RELEASE OF THE BAYER COMPANY Abstract  similar documents
article editorial
"... антикоагу- лянтов (НОАК) у пациентов с ФП и наличием тромбов в левом предсердии (ЛП) или ушке левого ..."
 
Vol 13, No 4 (2017) PATIENTS WITH ATRIAL FIBRILLATION IN MULTIDISCIPLINARY HOSPITAL: STRUCTURE OF HOSPITALIZATION, CONCOMITANT CARDIOVASCULAR DISEASES AND DRUG TREATMENT (DATA OF RECVASA AF-TULA REGISTRY) Abstract  similar documents
M. N. Valiakhmetov, T. A. Gomova, M. M. Loukianov, S. Yu. Martsevich, K. N. Nadejkina, M. N. Artemova, D. N. Jilin, E. E. Fedotova, A. V. Zagrebelnyy, E. V. Kudryashov, S. A. Boytsov
"... <0.0001), including anticoagulants (65.8% vs 48.3%, p<0.0001). The frequency of compliance of drug ..."
 
1 - 100 of 358 Items 1 2 3 4 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)